Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Almitrine
2. Almitrine Bis(methanesulfonate)
3. Almitrine Bismesylate
4. Almitrine Dimesylate
5. Almitrine Monomesylate
6. Monomesylate, Almitrine
7. Vectarion
1. Almitrine Dimesylate
2. 29608-49-9
3. Almitrine Bismesylate
4. Almitrine Dimethanesulfonate
5. Almitrine Dimesilate
6. Vectarion
7. Almitrine Mesilate
8. Almitrine Mesylate [usan]
9. Almitrine Bismesilate
10. 6ry6v6xm8t
11. 6-[4-[bis(4-fluorophenyl)methyl]piperazin-1-yl]-2-n,4-n-bis(prop-2-enyl)-1,3,5-triazine-2,4-diamine;methanesulfonic Acid
12. Chebi:53779
13. S-2620
14. N2,n4-diallyl-6-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1,3,5-triazine-2,4-diamine Dimethanesulfonate
15. Almitrine Mesylate (usan)
16. (diallylamino-4'-6'-triazinyl-2')-1-(bis P-fluorobenzydryl)-4 Piperazine Bis Methanesulfonate
17. 2,4-bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine Dimethanesulfonate
18. 6-(4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine Dimethanesulfonate
19. Unii-6ry6v6xm8t
20. S 2620 Bismethanesulfonate
21. Almitrine Bismethane Sulfonate
22. Almitrinemesylate
23. Vectarion (tn)
24. Einecs 249-726-1
25. Almitrine Bismethanesulfonate
26. Dsstox_cid_31492
27. Dsstox_rid_97377
28. Dsstox_gsid_57703
29. Schembl2228917
30. Chembl3181957
31. Dtxsid5057703
32. Tox21_113959
33. Almitrine Dimesilate [mart.]
34. Mfcd01679060
35. S4439
36. Almitrine Dimesilate [who-dd]
37. Akos027327548
38. Almitrine Dimethanesulfonate [mi]
39. Ncgc00262968-01
40. Ds-11817
41. Cas-29608-49-9
42. Hy-107319
43. Cs-0028130
44. D02822
45. 608a499
46. Q27104813
47. 1,3,5-triazine-2,4-diamine, 6-(4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-, Dimethanesulfonate
48. 2,4-bis(allylamino)-6-(4-(bis(p-fluorophenyl)methyl)-1-piperazinyl)-s-triazine Dimethanesulphonate
49. 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine Dimethanesulfonate
50. 6-4-(bis(4-fluorophenyl)methyl)-1-piperazinyl)-n,n'-di-2-propenyl-1,3,5-triazine-2,4-diamine Dimethanesulphonate
51. N,n'-diallyl-6-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1,3,5-triazine-2,4-diamine Dimethanesulphonate
52. N,n'-diallyl-6-{4-[bis(4-fluorophenyl)methyl]piperazin-1-yl}-1,3,5-triazine-2,4-diamine Dimethanesulfonate
53. N2,n4-diallyl-6-(4-(bis(4-fluorophenyl)methyl)piperazin-1-yl)-1,3,5-triazine-2,4-diaminedimethanesulfonate
| Molecular Weight | 669.8 g/mol |
|---|---|
| Molecular Formula | C28H37F2N7O6S2 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 15 |
| Rotatable Bond Count | 10 |
| Exact Mass | 669.22148060 g/mol |
| Monoisotopic Mass | 669.22148060 g/mol |
| Topological Polar Surface Area | 195 Ų |
| Heavy Atom Count | 45 |
| Formal Charge | 0 |
| Complexity | 694 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
Respiratory System Agents
Drugs used for their effects on the respiratory system. (See all compounds classified as Respiratory System Agents.)
ABOUT THIS PAGE
A Almitrine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Almitrine, including repackagers and relabelers. The FDA regulates Almitrine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Almitrine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Almitrine supplier is an individual or a company that provides Almitrine active pharmaceutical ingredient (API) or Almitrine finished formulations upon request. The Almitrine suppliers may include Almitrine API manufacturers, exporters, distributors and traders.
click here to find a list of Almitrine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Almitrine DMF (Drug Master File) is a document detailing the whole manufacturing process of Almitrine active pharmaceutical ingredient (API) in detail. Different forms of Almitrine DMFs exist exist since differing nations have different regulations, such as Almitrine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Almitrine DMF submitted to regulatory agencies in the US is known as a USDMF. Almitrine USDMF includes data on Almitrine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Almitrine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Almitrine suppliers with USDMF on PharmaCompass.
Almitrine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Almitrine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Almitrine GMP manufacturer or Almitrine GMP API supplier for your needs.
A Almitrine CoA (Certificate of Analysis) is a formal document that attests to Almitrine's compliance with Almitrine specifications and serves as a tool for batch-level quality control.
Almitrine CoA mostly includes findings from lab analyses of a specific batch. For each Almitrine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Almitrine may be tested according to a variety of international standards, such as European Pharmacopoeia (Almitrine EP), Almitrine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Almitrine USP).
LOOKING FOR A SUPPLIER?
